// App-Quantinova.ai

OP0160 (2022) : HLA-DRB1 ASSOCIATIONS WITH AUTOANTIBODY-DEFINED SUBGROUPS IN IDIOPATHIC INFLAMMATORY MYOPATHIES (IIM)

Researchers

Presenter

  • V. Leclair

Principal Investigators

  • A. S. Galindo-Feria

  • S. Rothwell

  • O. Krytufkov

  • H. Mann

  • L. Pyndt Diederichsen

  • H. Andersson

  • M. Klein

  • S. Tansley

  • N. Mchugh

  • J. Lamb

  • J. Vencovsk

  • H. Chinoy

  • M. Holmqvist

  • L. Padyukov

  • I. E. Lundberg

  • L. M. Diaz-Gallo

Medical Centers

  • Karolinska Institutet and Karolinska University Hospital, Division of Rheumatology and Clinical Epidemiology Division, Department Medicine Solna, Stockholm, Sweden

  • Jewish General Hospital Lady Davis Institute, Division of Rheumatology, Montreal, Canada

  • Karolinska Institutet and Karolinska University Hospital, Division of Rheumatology, Department Medicine Solna, Stockholm, Sweden

  • Karolinska Institutet, Center for Molecular Medicine, Department of Medicine Solna, Stockholm, Sweden

  • 1st Medical Faculty, Charles University, Institute of Rheumatologyand Department of Rheumatology, Prague, Czech Republic

  • Copenhagen University Hospital Rigshospitalet, Center for Rheumatology and Spine Diseases, København, Denmark

  • Odense University Hospital, Department of Hematology, Odense, Denmark

  • Oslo University Hospital, Department of Pathology, Oslo, Norway

  • University of Bath, Pharmacy and Pharmacology, Bath, United Kingdom

  • University of Manchester, Epidemiology and Public Health Group, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, Manchester, United Kingdom

  • The University of Manchester, National Institute for Health Research Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester, United Kingdom

  • Manchester Academic Health Science Centre, Department of Rheumatology, Salford Royal NHS Foundation Trust, Salford, United Kingdom

Locations

  • Sweden

  • Canada

  • United Kingdom

  • Czech Republic

  • Denmark

  • Norway

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Idiopathic inflammatory myopathies

Biomarkers

  • Major histocompatibility complex, class II, DR beta 1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • Abbvie

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved